PL377221A1 - Pochodne 1,2,4-triaminobenzenu - Google Patents

Pochodne 1,2,4-triaminobenzenu

Info

Publication number: PL377221A1
Authority: PL; Poland
Prior art keywords: nervous system; central nervous; treating disorders; derivatives useful; triaminobenzene derivatives
Prior art date: 2002-12-27

Application number

PL377221A

Other languages

English (en)

Inventor

Mario Rottländer

Andreas Ritzen

Noergaard Morten Bang

Nikolay Khanzhin

Tornoee Christian Wenzel

Original Assignee

H. Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-27

Filing date

2003-12-18

Publication date

2006-01-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL377221(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-18 Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S

2006-01-23 Publication of PL377221A1 publication Critical patent/PL377221A1/pl

Links

JSYBAZQQYCNZJE-UHFFFAOYSA-N benzene-1,2,4-triamine Chemical class NC1=CC=C(N)C(N)=C1 JSYBAZQQYCNZJE-UHFFFAOYSA-N 0.000 title 1
210000003169 central nervous system Anatomy 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL377221A 2002-12-27 2003-12-18 Pochodne 1,2,4-triaminobenzenu PL377221A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200202012		2002-12-27

Publications (1)

Publication Number	Publication Date
PL377221A1 true PL377221A1 (pl)	2006-01-23

Family

ID=35295526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL377221A PL377221A1 (pl)	2002-12-27	2003-12-18	Pochodne 1,2,4-triaminobenzenu

Country Status (16)

Country	Link
KR (1)	KR20050089862A (pl)
CN (1)	CN100448867C (pl)
AR (1)	AR042656A1 (pl)
BR (1)	BR0317748A (pl)
CL (1)	CL2003002748A1 (pl)
EA (1)	EA008589B1 (pl)
IS (1)	IS2649B (pl)
MY (1)	MY139844A (pl)
NO (1)	NO20053612L (pl)
PE (1)	PE20041015A1 (pl)
PL (1)	PL377221A1 (pl)
SI (1)	SI1578740T1 (pl)
TW (1)	TWI325414B (pl)
UA (1)	UA79666C2 (pl)
UY (1)	UY28151A1 (pl)
ZA (1)	ZA200504565B (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4200259A1 (de) *	1992-01-08	1993-07-15	Asta Medica Ag	Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) *	1995-10-26	1997-04-30	Asta Medica Ag	Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) *	1999-07-01	1999-09-01	Glaxo Group Ltd	Medical use
US6117900A (en) *	1999-09-27	2000-09-12	Asta Medica Aktiengesellschaft	Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) *	2000-12-20	2003-07-08	Wyeth	Methods of treating anxiety disorders

2003
- 2003-12-18 BR BR0317748-3A patent/BR0317748A/pt not_active IP Right Cessation
- 2003-12-18 TW TW092135930A patent/TWI325414B/zh not_active IP Right Cessation
- 2003-12-18 EA EA200501053A patent/EA008589B1/ru not_active IP Right Cessation
- 2003-12-18 KR KR1020057012183A patent/KR20050089862A/ko not_active Ceased
- 2003-12-18 SI SI200330827T patent/SI1578740T1/sl unknown
- 2003-12-18 UA UAA200507206A patent/UA79666C2/uk unknown
- 2003-12-18 CN CNB2003801076953A patent/CN100448867C/zh not_active Expired - Fee Related
- 2003-12-18 PL PL377221A patent/PL377221A1/pl unknown
- 2003-12-22 AR ARP030104782A patent/AR042656A1/es unknown
- 2003-12-24 CL CL200302748A patent/CL2003002748A1/es unknown
- 2003-12-24 UY UY28151A patent/UY28151A1/es not_active Application Discontinuation
- 2003-12-26 MY MYPI20035008A patent/MY139844A/en unknown
2004
- 2004-01-05 PE PE2004000037A patent/PE20041015A1/es not_active Application Discontinuation
2005
- 2005-05-23 IS IS7856A patent/IS2649B/is unknown
- 2005-06-03 ZA ZA200504565A patent/ZA200504565B/xx unknown
- 2005-07-25 NO NO20053612A patent/NO20053612L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TW200413280A (en)	2004-08-01
ZA200504565B (en)	2006-08-30
NO20053612D0 (no)	2005-07-25
EA008589B1 (ru)	2007-06-29
CN1732162A (zh)	2006-02-08
BR0317748A (pt)	2005-11-22
NO20053612L (no)	2005-09-23
IS2649B (is)	2010-08-15
TWI325414B (en)	2010-06-01
AR042656A1 (es)	2005-06-29
UA79666C2 (en)	2007-07-10
KR20050089862A (ko)	2005-09-08
SI1578740T1 (sl)	2007-08-31
IS7856A (is)	2005-05-23
CL2003002748A1 (es)	2005-04-08
CN100448867C (zh)	2009-01-07
HK1088317A1 (zh)	2006-11-03
MY139844A (en)	2009-11-30
PE20041015A1 (es)	2005-01-08
EA200501053A1 (ru)	2005-12-29
UY28151A1 (es)	2004-07-30

Similar Documents

Publication	Publication Date	Title
PL373626A1 (pl)	2005-09-05	Leczenie zaburzeń centralnego układu nerwowego
AU2003249983A8 (en)	2004-02-09	Piperidines useful for the treatment of central nervous system disorders
EP1705988A4 (en)	2010-08-18	IMMUNOMODULATING COMPOUNDS FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM
SI1572215T1 (sl)	2010-01-29	Benzo(d)azepinski derivati za zdravljenje nevroloĺ kih motenj
IL175055A0 (en)	2008-04-13	Combinations useful for the treatment of neuronal disorders
PL372425A1 (pl)	2005-07-25	Pochodne III dihydrobenzodiazepin-2-onu
MXPA03007960A (es)	2003-12-04	Compuestos y metodos para el tratamiento de desordenes urogenitales.
IL153425A0 (en)	2003-07-06	Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
AU2002212226A1 (en)	2002-03-22	Use of indole derivatives for treating illnesses of the central nervous system
IL155589A0 (en)	2003-11-23	Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU2002356525A1 (en)	2003-04-07	Substituted amines for the treatment of neurological disorders
AU7388101A (en)	2001-12-24	Indole derivatives useful for the treatment of cns disorders
IS2172B (is)	2006-11-15	Indól afleiður sem eru nytsamlegar fyrir meðhöndlun á taugakerfistruflunum
MXPA03001472A (es)	2003-06-06	Compuestos para el tratamiento de trastornos adictivos.
ZA200509169B (en)	2006-07-26	Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
ZA200504565B (en)	2006-08-30	1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system
WO2004048318A8 (en)	2005-05-12	Improved process for the preparation of 1,3-substituted indenes
SI1468686T1 (sl)	2007-04-30	S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj
IL153254A0 (en)	2003-07-06	Indole derivatives useful for the treatment of cns disorders
AU2003202255A8 (en)	2003-07-30	Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
IL136949A0 (en)	2001-06-14	1,4-diazacycloheptane derivatives for the treatment of neurological disorders
GB0010496D0 (en)	2000-06-14	Treatment of conditions of the central nervous system
NO20012538D0 (no)	2001-05-23	Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
AU2003228813A8 (en)	2003-11-17	Methods for treating neuronal disorders
GB0326967D0 (en)	2003-12-24	Use of pyrimidine derivatives for the treatment of psychiatric disorders

Legal Events

Date	Code	Title	Description
2013-04-30	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)